AnaptysBio (ANAB) News Today → AI finds its first serious application (From Wall Street Star) (Ad) Free ANAB Stock Alerts $26.60 +0.58 (+2.23%) (As of 01:16 PM ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineBuy Rating Affirmed for AnaptysBio on Positive Development Outlook and Market Potentialmarkets.businessinsider.com - May 2 at 10:50 AMAnaptysBio, Inc. (NASDAQ:ANAB) Given Consensus Recommendation of "Moderate Buy" by Brokeragesamericanbankingnews.com - May 1 at 3:12 AMAnaptysBio (NASDAQ:ANAB) Sees Strong Trading Volumemarketbeat.com - April 30 at 5:34 PMAnaptysBio (NASDAQ:ANAB) Shares Up 8.2%americanbankingnews.com - April 28 at 5:02 AMAnaptysBio (NASDAQ:ANAB) Stock Price Up 8.2%marketbeat.com - April 26 at 8:11 PMActym Therapeutics Appoints Thomas Smart as CEOprnewswire.com - April 24 at 9:00 AMAnaptysBio (NASDAQ:ANAB) Trading Down 5.9%marketbeat.com - April 18 at 4:55 PMQ1 2024 Earnings Estimate for AnaptysBio, Inc. Issued By Leerink Partnrs (NASDAQ:ANAB)marketbeat.com - April 18 at 5:59 AMLeerink Partners Initiates Coverage of AnaptysBio (ANAB) with Outperform Recommendationmsn.com - April 17 at 9:06 AMAnaptysBio (NASDAQ:ANAB) Trading Up 3.6%marketbeat.com - April 16 at 1:40 PMBTIG Research Predicts Over 118% Rally for These 3 Stocksinvestorplace.com - April 15 at 2:19 PMWhy AnaptysBio Stock Zoomed Nearly 8% Higher This Weekfool.com - April 12 at 7:00 PMAnaptysBio (NASDAQ:ANAB) Stock Price Down 8.2%marketbeat.com - April 12 at 4:32 PMVanguard Group Inc. Sells 72,916 Shares of AnaptysBio, Inc. (NASDAQ:ANAB)marketbeat.com - April 12 at 4:09 AMAnaptysBio (NASDAQ:ANAB) Research Coverage Started at Wells Fargo & Companymarketbeat.com - April 11 at 7:35 AMAnaptysBio (NASDAQ:ANAB) Trading 3.2% Higher marketbeat.com - April 10 at 4:23 PMAnaptysBio, Inc. (NASDAQ:ANAB) Receives Average Recommendation of "Moderate Buy" from Analystsmarketbeat.com - April 6 at 2:43 AMAnaptysBio (NASDAQ:ANAB) Trading Up 4%marketbeat.com - April 4 at 6:21 PMUnveiling 4 Analyst Insights On AnaptysBiomarkets.businessinsider.com - April 1 at 4:20 PMAnaptysBio (NASDAQ:ANAB) Stock Price Down 4.6% Following Analyst Downgrademarketbeat.com - April 1 at 2:58 PMDaniel Faga Sells 3,000 Shares of AnaptysBio, Inc. (NASDAQ:ANAB) Stockinsidertrades.com - March 27 at 5:26 AMInsider Selling: AnaptysBio, Inc. (NASDAQ:ANAB) CEO Sells 3,000 Shares of Stockmarketbeat.com - March 26 at 9:18 PMAnaptysBio (NASDAQ:ANAB) Stock Price Down 5.1%marketbeat.com - March 22 at 2:31 PMIndustry Analysts Just Made A Stunning Upgrade To Their AnaptysBio, Inc. (NASDAQ:ANAB) Revenue Forecastsfinance.yahoo.com - March 18 at 9:54 AMAnaptysBio, Inc. (NASDAQ:ANAB) Short Interest Updatemarketbeat.com - March 18 at 12:48 AMHudson Bay Capital Management LP Increases Stock Holdings in AnaptysBio, Inc. (NASDAQ:ANAB)marketbeat.com - March 17 at 5:11 AMQ1 2024 EPS Estimates for AnaptysBio, Inc. Lifted by Analyst (NASDAQ:ANAB)marketbeat.com - March 14 at 6:40 AMAnaptysBio (NASDAQ:ANAB) Trading Down 3.8%marketbeat.com - March 13 at 2:16 PMSkin Disease-Focused AnaptysBio Earns Analyst Upgrade On Positive Outlook For Clinical Triggersmarkets.businessinsider.com - March 12 at 7:45 PMWedbush raises AnaptysBio to outperform, cites upcoming dataseekingalpha.com - March 12 at 2:03 PMJ.P. Morgan Reaffirms Their Hold Rating on AnaptysBio (ANAB)markets.businessinsider.com - March 12 at 2:03 PMAnaptysBio, Inc.: Anaptys Announces Fourth Quarter and Full Year 2023 Financial Results and Provides Business Updatefinanznachrichten.de - March 12 at 9:02 AMAnaptysBio (NASDAQ:ANAB) Raised to "Outperform" at Wedbushmarketbeat.com - March 12 at 7:28 AMAnaptys Announces Fourth Quarter and Full Year 2023 Financial Results and Provides Business Updateglobenewswire.com - March 11 at 4:15 PMANAB Mar 2024 20.000 callfinance.yahoo.com - March 11 at 10:17 AMAnaptysBio, Inc. (NASDAQ:ANAB) Sees Significant Drop in Short Interestmarketbeat.com - March 3 at 6:58 AMBraidwell LP Sells 104,600 Shares of AnaptysBio, Inc. (NASDAQ:ANAB)marketbeat.com - March 1 at 10:18 AMAnaptys to Present at TD Cowen's 44th Annual Health Care Conference and 2024 AAD Annual Meetingglobenewswire.com - February 29 at 9:15 AMBTIG Initiates Coverage of AnaptysBio (ANAB) with Buy Recommendationmsn.com - February 27 at 3:42 PMAnaptysBio (ANAB) Set to Announce Earnings on Wednesdaymarketbeat.com - February 27 at 7:27 AMAnaptysBio (NASDAQ:ANAB) Now Covered by Analysts at BTIG Researchmarketbeat.com - February 26 at 8:11 AMAnaptysBio (ANAB) Price Target Increased by 40.21% to 38.61msn.com - February 24 at 9:45 AMRafferty Asset Management LLC Lowers Stock Position in AnaptysBio, Inc. (NASDAQ:ANAB)marketbeat.com - February 24 at 5:35 AMAnaptysBio (NASDAQ:ANAB) Reaches New 12-Month High at $25.92marketbeat.com - February 23 at 2:57 PMAnaptysBio Stock (NASDAQ:ANAB) Insider Tradesbenzinga.com - February 22 at 12:26 PMStifel Initiates Coverage of AnaptysBio (ANAB) with Buy Recommendationmsn.com - February 22 at 2:25 AMStifel starts AnaptysBio at buy, cites upcoming catalystsmsn.com - February 21 at 4:25 PMPalo Alto Networks, Home Depot downgraded: Wall Street's top analyst callsmsn.com - February 21 at 11:24 AMAnaptysbio a key player in next wave of immune cell modulatory therapies - Stifelinvesting.com - February 21 at 11:24 AMAnaptysBio (NASDAQ:ANAB) Now Covered by Analysts at Stifel Nicolausmarketbeat.com - February 21 at 7:17 AM Get AnaptysBio News Delivered to You Automatically Sign up to receive the latest news and ratings for ANAB and its competitors with MarketBeat's FREE daily newsletter. Email Address The Long-Awaited End of America Update (Ad)A 995% Gain Last Time We Shared this "Election Secret" It's a straightforward way to come out on top no matter who wins this November… It's not cryptos, or options, and anyone can do it. Click here to find out for free. ANAB Media Mentions By Week ANAB Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ANAB News Sentiment▼0.810.33▲Average Medical News Sentiment ANAB News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ANAB Articles This Week▼52▲ANAB Articles Average Week Get AnaptysBio News Delivered to You Automatically Sign up to receive the latest news and ratings for ANAB and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Y-mAbs Therapeutics News Today Disc Medicine News Today Silence Therapeutics News Today Phibro Animal Health News Today Nuvation Bio News Today Evolus News Today Arcturus Therapeutics News Today Savara News Today Pharming Group News Today Dianthus Therapeutics News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ANAB) was last updated on 5/2/2024 by MarketBeat.com Staff From Our PartnersAI finds its first serious applicationWall Street StarHave You Seen Elon’s New A.I. Device? (Picture Inside)InvestorPlaceHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportA.I. is a Tidal Wave - Here’s What to BuyChaikin AnalyticsProtect Your Bank Account Before It’s Too LateWeiss RatingsDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsA once-in-a-century investment opportunityStansberry ResearchPOTUS in ‘25 Not Biden/Trump, ButThe Freeport Society Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding AnaptysBio, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
